29 - 31 October, 2019 | Twickenham Stadium, London, United Kingdom

Cell and Gene Therapy Manufacturing Forum News

Download the Cell and Gene Therapy Manufacturing Agenda

Optimise every facet of your manufacturing strategy by participating at the Cell and Gene Therapy Manufacturing Forum.Benefits of attending: Join a curated programme taking you from translation and collaboration to ensuring GMP compliance and optimising scalabi ...

Featured Download

Cell and Gene Therapy: European Heatmap 2019

Back by popular demand, the 2019 industry heatmap provides a high level overview of the latest developments in the European novel therapy manufacturing space across The United Kingdom, Belgium, Greece and Switzerland,

Cell and Gene Therapy: Heatmap and Industry Update 2019

With many therapies advancing to later clinical trial phases and moving even closer to commercialisation, Pharma IQ have created an industry report overview of the key European cell and gene therapies, pinpointi ...

Presentation: Designing a cost effective supply chain for cell therapy

Download this free presentation on how to design a robust and cost-effective ‘off-the-shelf’ supply chain for your cell therapy. With insights from Bone Therapeutics’ PhD Production Associate Director, Anne-Sophie LeBrun, this presentation is designed to ensure that your manufacturing proc ...

Cell & Gene Therapy: Heatmap & Industry Update

The cell and gene therapy manufacturing sphere continues to mature rapidly, with a growing number of companies moving towards commercialising products. This report includes a European Heatmap which provides a high level overview of the latest developments in the European cell and gene therapy man ...

Addressing Scalability Challenges in Cell Therapy Manufacturing

As cell and gene therapy production continues to move towards commercialisation, it faces new challenges relating to the scalability of manufacturing processes. Both autologous and allogeneic therapies hold their own unique obstacles relating to production and treatment; and the promise of person ...

Overcoming Manufacturing Challenges in the Race to Market

Fast on its way to becoming a multibillion-dollar market, the global cell and gene therapy industry is booming. However, challenges mean that almost three decades after the first gene therapy trial, only three gene therapies have been approved in the EU and one in the United States. This article ...

Cell & Gene Therapy: European Heatmap

The cell and gene therapy manufacturing sphere continues to mature rapidly, with a growing number of companies moving towards commercialising products. This infographic provides a high level overview of the latest developments in the European cell and gene therapy manufacturing space, looking at ...

Making Medicines of The Future

In this case study, Pharma IQ gains insight from Oxford BioMedica - a pioneer in the development of gene therapies for 20 years, focused mainly on lentiviral vectors. The ebook evaluates manufacturing trends, preparing for the commercial phases of gene therap ...

Cell And Gene Manufacturing UK Heatmap

In response to the region’s strengthening presence with the therapeutic method, Pharma IQ presents this Cell and Gene Manufacturing hotspot map.

Cell and Gene Therapy Europe Heatmap

Over the last 12 months, the cell and gene therapy manufacturing sphere has matured vastly with more companies advancing to commercial products, especially with allogenic therapies. Now that the theory behind the therapy is catching up with the technology, the two can come together to progress towar ...

Producing Off-The-Shelf Cell and Gene Products

The rise of personalised medicines has led to the focus on small scale manufacture with a key challenge being that lots of the same element will run through a facility at once. Randomised trials with complex gene therapies- which target a small number of patients often in regards to orphan diseases ...

Sponsorship enquiry

Cell and Gene Therapy: European Heatmap 2019:

Back by popular demand, the 2019 industry heatmap provides a high level overview of the latest developments in the European novel therapy manufacturing space across The United Kingdom, Belgium, Greece and Switzerland, among others. With the 2018 commercialisation of prominent Autologous therapies such as KITEs Yskarta and Novartis’ Kymriah in...

Cell and Gene Therapy Manufacturing Programme

Optimise every facet of your manufacturing strategy by participating at the Cell and Gene Therapy Manufacturing Forum.Benefits of attending: Join a curated programme taking you from translation and collaboration to ensuring GMP compliance and optimising scalability - this year’s forum is your one-stop shop for building manufacturing capabilities that are compliant, efficient and commercialEngage in...

Additional Content Download

Cell & Gene Manufacturing: Emerging Trends

Pharma IQ spoke to Dr Ryan Guest, Director of Cell Production from cell therapy manufacturer Cellular Therapeutics to explore the raft of emerging trends connected to cell and gene manufacturing.

Stem Cells: The Big Void of Toxicological Testing?

In this interview Pharma IQ speak to James Sherley to find out what have been the major advancements in using stem cells for toxicology testing and the current challenges that need to be overcome in using stem cells for toxicology. In this interview you will also find out what are...

INFOGRAPHIC: Global biomanufacturing activity & spend

Pharma IQ has created an easy-to-digest overview of biomanufacturing activity and spend around the world, whether they are already being implemented or have plans in the near future. You’ll be able to keep it as a handy reference, share it around your colleagues or even stick it on your wall!

Scale-Up and Manufacturing of Regenerative Medicine

When introducing a regenerative medicine cell based product to a commercial setting, there are a number of things to take into consideration to ensure a commercially viable and safe product for patient use. In this Q&A interview, William Fodor, Director of Translational Sciences, Cell Therapy Group, gives some great insights...

Past Presentation: Identify the Opportunities and Challenges in Advanced Therapy Manufacturing Process (ATMP)

Magda Papadaki, Head of Manufacturing Innovation, The Association of the British Pharmaceutical Industry (ABPI) shares her presentation from last year's Cell & Gene Therapy Manufacturing Forum: 'Identify the Opportunities and Challenges in Advanced Therapy Manufacturing Process (ATMP)'.In this presentation:Determine what to consider when moving from research to commercial productionUnderstand what...